Request Deal Involvement
China Structural Reform Fund led a $149m Series E round in Genecast Biotechnology.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Sard Verbinnen & Co
or
Principals
bidder
TAIKANG ASSET MANAGEMENT
target
GENECAST BIOTECHNOLOGY
bidder
CHINA RENAISSANCE HOLDINGS LTD
bidder
HILLHOUSE CAPITAL GROUP
bidder
CCB INTERNATIONAL
bidder
CHINA STRUCTURAL REFORM FUND CORPORATION LIMITED
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite